Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects

Diabetes

Volumn 56, Issue 11, 2007, Pages 2759-2765

  Westerbacka, Jukka ^a   Kolak, Maria ^b   Kiviluoto, Tuula ^a   Arkkila, Perttu ^a   Sirén, Jukka ^a   Hamsten, Anders ^b   Fisher, Rachel M ^b   Yki Järvinen, Hannele ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COA SYNTHETASE LONG CHAIN FAMILY MEMBER 4 ENZYME; ADIPONECTIN; C PEPTIDE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 4; FATTY ACID BINDING PROTEIN 5; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN LIPASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY LIVER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID STORAGE; LIPOLYSIS; LIVER BIOPSY; MALE; MONOCYTE; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CHEMOKINE CCL2; FATTY ACIDS; FATTY LIVER; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INSULIN RESISTANCE; LIPOLYSIS; LIPOPROTEIN LIPASE; MACROPHAGES; MONOCYTES; POLYMERASE CHAIN REACTION; PPAR GAMMA; REFERENCE VALUES; RNA, MESSENGER;

EID: 35748972366     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db07-0156     Document Type: Article

References (48)

1. Yki-Jarvinen H, Westerbacka J: The fatty liver and insulin resistance. Curr Mol Med 5:287-295, 2005
2. Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37:1202-1219, 2003
3. Festa A, D'Agostino R Jr, Howard G, et al.: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42-47, 2000
4. Sartipy P, Loskutoff DJ: Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100:7265-7270, 2003
5. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW: CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116:115-124, 2006
6. Weisberg SP, McCann D, Desai M, et al.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808, 2003
7. Westerbacka J, Corner A, Kannisto K, et al.: Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects. Diabetologia 49:132-140, 2006
8. Xu H, Barnes GT, Yang Q, et al.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830, 2003
9. Alessi MC, Bastelica D, Mavri A, et al.: Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol 23:1262-1268, 2003
10. Yki-Jarvinen H, Sutinen J, Silveira A, et al.: Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy. Arterioscler Thromb Vasc Biol 23:688-694, 2003
11. Donnelly KL, Smith CI, Schwarzenberg SJ, et al.: Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343-1351, 2005
12. Doege H, Baillie RA, Ortegon AM, et al.: Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology 130:1245-1258, 2006
13. Maeda K, Cao H, Kono K, et al.: Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab 1:107-119, 2005
14. Newberry EP, Xie Y, Kennedy SM, et al.: Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 44:1191-1205, 2006
15. Gavrilova O, Haluzik M, Matsusue K, et al.: Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 278:34268-34276, 2003
16. Sutinen J, Kannisto K, Korsheninnikova E, et al.: Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab 286:E941-E949, 2004
17. Younossi ZM, Baranova A, Ziegler K, et al.: A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology 42:665-674, 2005
18. Younossi ZM, Gorreta F, Ong JP, et al.: Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int 25:760-771, 2005
19. Chiappini F, Barrier A, Saffroy R, et al.: Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab Invest 86:154-165, 2006
20. Haukeland JW, Damas JK, Konopski Z, et al.: Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44:1167-1174, 2006
21. Chmurzynska A: The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 47:39-48, 2006
22. Amri EZ, Bertrand B, Ailhaud G: Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. J Lipid Res 32:1449-1456, 1991
23. Makowski L, Boord JB, Maeda K, et al.: Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7:699-705, 2001
24. Krieg P, Feil S, Furstenberger G, et al.: Tumor-specific overexpression of a novel keratinocyte lipid-binding protein: identification and characterization of a cloned sequence activated during multistage carcinogenesis in mouse skin. J Biol Chem 268:17362-17369, 1993
25. Memon RA, Fuller J, Moser AH, et al.: Regulation of putative fatty acid transporters and Acyl-CoA synthetase in liver and adipose tissue in ob/ob mice. Diabetes 48:121-127, 1999
26. Kirchgessner TG, Svenson KL, Lusis AJ, et al.: The sequence of cDNA encoding lipoprotein lipase: a member of a lipase gene family. J Biol Chem 262:8463-8466, 1987
27. Zhang Y, Repa JJ, Gauthier K, et al.: Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J Biol Chem 276:43018-43024, 2001
28. Enerback S, Semb H, Tavernier J, et al.: Tissue-specific regulation of guinea pig lipoprotein lipase: effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver. Gene 64:97-106, 1988
29. Chajek T, Stein O, Stein Y: Pre- and post-natal development of lipoprotein lipase and hepatic triglyceride hydrolase activity in rat tissues. Atherosclerosis 26:549-561, 1977
30. Kim JK, Fillmore JJ, Chen Y, et al.: Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 98:7522-7527, 2001
31. Ong JM, Kern PA: Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. J Clin Invest 84:305-311, 1989
32. Coleman RA, Lewin TM, Van Horn CG, et al.: Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J Nutr 132:2123-2126, 2002
33. Mashek DG, Li LO, Coleman RA: Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet. J Lipid Res 47:2004-2010, 2006
34. Mashek DG, McKenzie MA, Van Horn CG, et al.: Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells. J Biol Chem 281:945-950, 2006
35. Kang MJ, Fujino T, Sasano H, et al.: A novel arachidonate-preferring acyl-CoA synthetase is present in steroidogenic cells of the rat adrenal, ovary, and testis. Proc Natl Acad Sci U S A 94:2880-2884, 1997
36. Matsusue K, Haluzik M, Lambert G, et al.: Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111:737-747, 2003
37. Yu S, Matsusue K, Kashireddy P, et al.: Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem 278:498-505, 2003
38. Schadinger SE, Bucher NL, Schreiber BM, et al.: PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am J Physiol Endocrinol Metab 288:E1195-E1205, 2005
39. Ferre P: The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 (Suppl. 1):S43-S50, 2004
40. Tiikkainen M, Bergholm R, Vehkavaara S, et al.: Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52:701-707, 2003
41. Pietilainen KH, Rissanen A, Kaprio J, et al.: Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab 288: E768-E774, 2005
42. Westerbacka J, Lammi K, Hakkinen AM, et al.: Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90:2804-2809, 2005
43. Sampath H, Miyazaki M, Dobrzyn A, et al.: Stearoyl CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem 282:2483-2493, 2007
44. Lin J, Yang R, Tarr PT, et al.: Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 120:261-273, 2005
45. Miyazaki M, Kim YC, Gray-Keller MP, et al.: The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem 275:30132-30138, 2000
46. Rosen ED, Spiegelman BM: PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276:37731-37734, 2001
47. Sun X, Han R, Wang Z, et al.: Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Diabetologia 49:1303-1310, 2006
48. Yki-Jarvinen H: Thiazolidinediones. N Engl J Med 351:1106-1118, 2004